Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxypachymic acid capsules plus entecavir in chronic hepatitis B liver fibrosis
CTR20160699Phase 2Completed
- Sponsor
- Shanghai Ruixing Genetic Technology
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxypachymic acid in Chronic Hepatitis B (CHB), hepatic fibrosis, sponsored by Shanghai Ruixing Genetic Technology. Started Nov 2018; status: completed.
02
Drugs
hydroxypachymic acid
03
Conditions
Chronic Hepatitis B (CHB)hepatic fibrosis
Beyond the preview
Go deeper on CTR20160699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160699.